Insider Transactions in Q3 2022 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2022
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,000
-7.01%
|
$48,000
$12.4 P/Share
|
|
Sep 27
2022
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+6.55%
|
$16,000
$4.3 P/Share
|
|
Aug 08
2022
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,385
-2.55%
|
$20,775
$15.01 P/Share
|
|
Aug 08
2022
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,385
+2.48%
|
$5,540
$4.3 P/Share
|
|
Aug 04
2022
|
Vision Scs F2 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,989
-2.03%
|
$363,846
$14.31 P/Share
|
|
Aug 03
2022
|
Vision Scs F2 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
19,129
-1.47%
|
$267,806
$14.24 P/Share
|
|
Aug 02
2022
|
Vision Scs F2 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,792
-0.37%
|
$67,088
$14.1 P/Share
|
|
Jul 25
2022
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-13.11%
|
$112,000
$14.51 P/Share
|
|
Jul 25
2022
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+11.59%
|
$32,000
$4.3 P/Share
|
|
Jul 19
2022
|
Corrine Savill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
14,958
-9.09%
|
$224,370
$15.22 P/Share
|
|
Jul 18
2022
|
Corrine Savill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,042
-2.97%
|
$75,630
$15.06 P/Share
|
|
Jul 11
2022
|
Corrine Savill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
40,000
-9.55%
|
$520,000
$13.59 P/Share
|